AptarGroup, Inc. (NYSE:ATR) Stock Has Average Target Price of $164.14

Shares of AptarGroup, Inc. (NYSE:ATR) have received an average rating of “Moderate Buy” from the eight brokerages that are covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $164.14.

ATR has been the subject of a number of research analyst reports. Wells Fargo & Company raised their price objective on shares of AptarGroup from $145.00 to $155.00 and gave the stock an “overweight” rating in a report on Monday, August 3rd. Weiss Ratings reiterated a “hold (c)” rating on shares of AptarGroup in a research note on Monday, September 21st. Deutsche Bank started coverage on shares of AptarGroup in a research report on Wednesday, October 7th. They set a “buy” rating and a $150.00 target price for the company. Bank of America restated a “buy” rating on shares of AptarGroup in a research note on Monday, November 2nd. Finally, UBS Group assumed coverage on shares of AptarGroup in a research note on Friday, October 9th. They set a “neutral” rating and a $135.00 price target for the company.

Top AptarGroup Stories

These are some of the ATR stories that stood out recently:

• Positive Sentiment: Zacks Research lifted its FY2026 EPS estimate to $5.53 from $5.46, FY2027 to $5.91 from $5.90, and FY2028 to $6.65 from $6.53. It also raised estimates for several upcoming quarters, including Q4 2026, Q1–Q3 2027 and Q1–Q3 2028. The broad upward revisions could support investor optimism about AptarGroup’s earnings outlook.
• Negative Sentiment: Zacks Research reduced its Q4 2027 EPS forecast to $1.46 from $1.49, a limited offset to the generally higher estimates.

Insider Buying and Selling at AptarGroup

In other AptarGroup news, insider Shiela Vinczeller sold 765 shares of the business’s stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $130.37, for a total value of $99,733.05. Following the sale, the insider directly owned 26,313 shares in the company, valued at $3,430,425.81. The trade was a 2.83% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Gael Touya sold 3,740 shares of the company’s stock in a transaction on Thursday, August 27th. The shares were sold at an average price of $133.76, for a total value of $500,262.40. Following the transaction, the chief executive officer directly owned 29,102 shares in the company, valued at $3,892,683.52. This represents a 11.39% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.73% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On AptarGroup

Several large investors have recently added to or reduced their stakes in the company. Empowered Funds LLC purchased a new position in shares of AptarGroup in the second quarter worth about $990,000. California State Teachers Retirement System lifted its stake in shares of AptarGroup by 24.4% in the 1st quarter. California State Teachers Retirement System now owns 77,227 shares of the industrial products company’s stock valued at $9,732,000 after acquiring an additional 15,158 shares during the last quarter. Bank of America Corp DE lifted its stake in shares of AptarGroup by 7.2% in the 1st quarter. Bank of America Corp DE now owns 485,718 shares of the industrial products company’s stock valued at $61,210,000 after acquiring an additional 32,420 shares during the last quarter. First Trust Advisors LP boosted its holdings in AptarGroup by 42.6% during the 1st quarter. First Trust Advisors LP now owns 538,554 shares of the industrial products company’s stock valued at $67,868,000 after acquiring an additional 160,763 shares during the period. Finally, Chicago Partners Investment Group LLC purchased a new stake in AptarGroup during the 1st quarter valued at about $505,000. Hedge funds and other institutional investors own 88.52% of the company’s stock.

AptarGroup Stock Performance

NYSE:ATR traded up $1.40 during trading on Thursday, reaching $143.12. The company’s stock had a trading volume of 546,912 shares, compared to its average volume of 528,734. AptarGroup has a 12 month low of $110.95 and a 12 month high of $148.63. The firm has a market cap of $9.07 billion, a price-to-earnings ratio of 34.74, a price-to-earnings-growth ratio of 4.13 and a beta of 0.33. The firm has a 50 day moving average of $128.06 and a 200-day moving average of $127.94. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.03 and a current ratio of 1.50.

AptarGroup (NYSE:ATR) last released its earnings results on Thursday, October 29th. The industrial products company reported $1.52 EPS for the quarter, topping analysts’ consensus estimates of $1.47 by $0.05. The company had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $980.76 million. AptarGroup had a return on equity of 13.11% and a net margin of 6.69%. The business’s revenue for the quarter was up 6.0% compared to the same quarter last year. During the same period in the previous year, the business posted $1.62 EPS. Research analysts expect that AptarGroup will post 5.56 EPS for the current fiscal year.

AptarGroup Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 3rd. Shareholders of record on Thursday, November 12th will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.4%. This is a positive change from AptarGroup’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Thursday, November 12th. AptarGroup’s dividend payout ratio is currently 48.54%.

AptarGroup Company Profile

AptarGroup is a global provider of dispensing, packaging and drug-delivery solutions. Its products include pumps, aerosol valves, sprayers, closures and other components used to package and dispense products. The company serves customers in the pharmaceutical, beauty, personal care, food and beverage markets. Its pharmaceutical offerings include systems and components for delivering medicines through nasal, inhaled, ophthalmic and injectable applications, while its packaging solutions help consumer brands dispense and protect products.